IGF-1 is not a dietary aid and cannot alone stimulate weight loss
Read the full blog for essential tips on medication safety
[] Both GLP-1 and glucagon-like peptide-2 (GLP-2) show approximately 50% sequence homology with glucagon
Participants stigmatized an individual who had regained weight after using a GLP-1, rating them less favorably than an individual who had lost weight and maintained it (i.e., higher in negative traits, lower in positive traits, more unhealthy, less willing to affiliate) and less favorably, again, than even an individual who had not attempted weight loss (i.e., lower in positive traits)
Product Overview Methodology Note: This product summary references published preclinical and clinical research
The combination offers hope for patients who've plateaued on GLP-1s alone or need maximum weight loss